nodes	percent_of_prediction	percent_of_DWPC	metapath
Fluoxetine—ABCB1—colon cancer	0.333	1	CbGaD
Fluoxetine—CYP2B6—Irinotecan—colon cancer	0.0465	0.116	CbGbCtD
Fluoxetine—ALB—Irinotecan—colon cancer	0.0456	0.113	CbGbCtD
Fluoxetine—ALB—Fluorouracil—colon cancer	0.0437	0.109	CbGbCtD
Fluoxetine—CYP2C9—Capecitabine—colon cancer	0.0397	0.0989	CbGbCtD
Fluoxetine—CYP3A5—Irinotecan—colon cancer	0.0366	0.0911	CbGbCtD
Fluoxetine—CYP3A5—Vincristine—colon cancer	0.032	0.0796	CbGbCtD
Fluoxetine—CYP1A2—Fluorouracil—colon cancer	0.0262	0.0651	CbGbCtD
Fluoxetine—ALB—Methotrexate—colon cancer	0.0241	0.06	CbGbCtD
Fluoxetine—ABCB1—Irinotecan—colon cancer	0.0238	0.0593	CbGbCtD
Fluoxetine—CYP2C9—Fluorouracil—colon cancer	0.0236	0.0586	CbGbCtD
Fluoxetine—ABCB1—Vincristine—colon cancer	0.0208	0.0518	CbGbCtD
Fluoxetine—CYP3A4—Irinotecan—colon cancer	0.0143	0.0355	CbGbCtD
Fluoxetine—ABCB1—Methotrexate—colon cancer	0.0126	0.0314	CbGbCtD
Fluoxetine—CYP3A4—Vincristine—colon cancer	0.0125	0.031	CbGbCtD
Fluoxetine—ORM1—bile—colon cancer	0.00827	0.171	CbGeAlD
Fluoxetine—HTR2A—myenteric nerve plexus—colon cancer	0.00538	0.111	CbGeAlD
Fluoxetine—HTR2A—vein—colon cancer	0.00347	0.0716	CbGeAlD
Fluoxetine—ORM1—gall bladder—colon cancer	0.0023	0.0474	CbGeAlD
Fluoxetine—ALB—gall bladder—colon cancer	0.00201	0.0416	CbGeAlD
Fluoxetine—HTR2A—endothelium—colon cancer	0.00119	0.0246	CbGeAlD
Fluoxetine—HTR2A—blood vessel—colon cancer	0.0011	0.0227	CbGeAlD
Fluoxetine—SIGMAR1—smooth muscle tissue—colon cancer	0.000969	0.02	CbGeAlD
Fluoxetine—ORM1—bone marrow—colon cancer	0.000833	0.0172	CbGeAlD
Fluoxetine—SLC6A4—digestive system—colon cancer	0.00077	0.0159	CbGeAlD
Fluoxetine—ABCB1—blood vessel—colon cancer	0.000721	0.0149	CbGeAlD
Fluoxetine—SIGMAR1—bone marrow—colon cancer	0.000705	0.0146	CbGeAlD
Fluoxetine—SIGMAR1—vagina—colon cancer	0.000675	0.0139	CbGeAlD
Fluoxetine—ORM1—liver—colon cancer	0.000673	0.0139	CbGeAlD
Fluoxetine—HTR2A—embryo—colon cancer	0.000656	0.0136	CbGeAlD
Fluoxetine—CYP2C19—digestive system—colon cancer	0.000638	0.0132	CbGeAlD
Fluoxetine—CYP1A2—renal system—colon cancer	0.000635	0.0131	CbGeAlD
Fluoxetine—CYP3A5—renal system—colon cancer	0.000613	0.0127	CbGeAlD
Fluoxetine—CYP2B6—renal system—colon cancer	0.000609	0.0126	CbGeAlD
Fluoxetine—ALB—liver—colon cancer	0.00059	0.0122	CbGeAlD
Fluoxetine—SIGMAR1—liver—colon cancer	0.00057	0.0118	CbGeAlD
Fluoxetine—CYP2C19—vagina—colon cancer	0.000563	0.0116	CbGeAlD
Fluoxetine—HTR2A—epithelium—colon cancer	0.000536	0.0111	CbGeAlD
Fluoxetine—CYP1A2—digestive system—colon cancer	0.000521	0.0108	CbGeAlD
Fluoxetine—ORM1—lymph node—colon cancer	0.000516	0.0107	CbGeAlD
Fluoxetine—HTR2A—smooth muscle tissue—colon cancer	0.000516	0.0107	CbGeAlD
Fluoxetine—CYP2B6—lymphoid tissue—colon cancer	0.000506	0.0104	CbGeAlD
Fluoxetine—CYP3A5—digestive system—colon cancer	0.000503	0.0104	CbGeAlD
Fluoxetine—CYP2B6—digestive system—colon cancer	0.0005	0.0103	CbGeAlD
Fluoxetine—HTR2A—renal system—colon cancer	0.000497	0.0103	CbGeAlD
Fluoxetine—CYP2C9—digestive system—colon cancer	0.000495	0.0102	CbGeAlD
Fluoxetine—CYP2C19—liver—colon cancer	0.000475	0.00981	CbGeAlD
Fluoxetine—CYP3A4—renal system—colon cancer	0.00046	0.0095	CbGeAlD
Fluoxetine—ALB—lymph node—colon cancer	0.000453	0.00935	CbGeAlD
Fluoxetine—CYP2D6—renal system—colon cancer	0.000453	0.00934	CbGeAlD
Fluoxetine—CYP3A5—vagina—colon cancer	0.000444	0.00916	CbGeAlD
Fluoxetine—CYP2B6—vagina—colon cancer	0.000441	0.00911	CbGeAlD
Fluoxetine—SIGMAR1—lymph node—colon cancer	0.000437	0.00902	CbGeAlD
Fluoxetine—ABCB1—embryo—colon cancer	0.00043	0.00888	CbGeAlD
Fluoxetine—HTR2A—digestive system—colon cancer	0.000407	0.00841	CbGeAlD
Fluoxetine—CYP1A2—liver—colon cancer	0.000388	0.00802	CbGeAlD
Fluoxetine—SLC6A2—lymph node—colon cancer	0.000387	0.00799	CbGeAlD
Fluoxetine—CYP3A4—digestive system—colon cancer	0.000377	0.00779	CbGeAlD
Fluoxetine—CYP3A5—liver—colon cancer	0.000374	0.00773	CbGeAlD
Fluoxetine—CYP2B6—liver—colon cancer	0.000372	0.00768	CbGeAlD
Fluoxetine—CYP2D6—digestive system—colon cancer	0.000371	0.00766	CbGeAlD
Fluoxetine—CYP2C9—liver—colon cancer	0.000369	0.00761	CbGeAlD
Fluoxetine—HTR2A—vagina—colon cancer	0.00036	0.00743	CbGeAlD
Fluoxetine—ABCB1—epithelium—colon cancer	0.000351	0.00725	CbGeAlD
Fluoxetine—ABCB1—renal system—colon cancer	0.000326	0.00672	CbGeAlD
Fluoxetine—HTR2A—liver—colon cancer	0.000304	0.00627	CbGeAlD
Fluoxetine—CYP3A4—liver—colon cancer	0.000281	0.0058	CbGeAlD
Fluoxetine—CYP2D6—liver—colon cancer	0.000277	0.00571	CbGeAlD
Fluoxetine—ABCB1—lymphoid tissue—colon cancer	0.00027	0.00558	CbGeAlD
Fluoxetine—ABCB1—digestive system—colon cancer	0.000267	0.00551	CbGeAlD
Fluoxetine—ABCB1—bone marrow—colon cancer	0.000246	0.00508	CbGeAlD
Fluoxetine—ABCB1—vagina—colon cancer	0.000236	0.00487	CbGeAlD
Fluoxetine—ABCB1—liver—colon cancer	0.000199	0.00411	CbGeAlD
Fluoxetine—Anaphylactic shock—Vincristine—colon cancer	0.000188	0.000865	CcSEcCtD
Fluoxetine—Stomatitis—Capecitabine—colon cancer	0.000187	0.000862	CcSEcCtD
Fluoxetine—Jaundice—Capecitabine—colon cancer	0.000187	0.000862	CcSEcCtD
Fluoxetine—Infection—Vincristine—colon cancer	0.000187	0.00086	CcSEcCtD
Fluoxetine—Conjunctivitis—Capecitabine—colon cancer	0.000187	0.00086	CcSEcCtD
Fluoxetine—Urinary tract infection—Capecitabine—colon cancer	0.000187	0.00086	CcSEcCtD
Fluoxetine—Convulsion—Fluorouracil—colon cancer	0.000186	0.000857	CcSEcCtD
Fluoxetine—Osteoarthritis—Methotrexate—colon cancer	0.000185	0.000854	CcSEcCtD
Fluoxetine—Confusional state—Irinotecan—colon cancer	0.000184	0.00085	CcSEcCtD
Fluoxetine—Thrombocytopenia—Vincristine—colon cancer	0.000184	0.000847	CcSEcCtD
Fluoxetine—Haematuria—Capecitabine—colon cancer	0.000183	0.000843	CcSEcCtD
Fluoxetine—Anaphylactic shock—Irinotecan—colon cancer	0.000183	0.000843	CcSEcCtD
Fluoxetine—Myalgia—Fluorouracil—colon cancer	0.000183	0.000842	CcSEcCtD
Fluoxetine—Chest pain—Fluorouracil—colon cancer	0.000183	0.000842	CcSEcCtD
Fluoxetine—Infection—Irinotecan—colon cancer	0.000182	0.000837	CcSEcCtD
Fluoxetine—Hyperhidrosis—Vincristine—colon cancer	0.000182	0.000837	CcSEcCtD
Fluoxetine—Epistaxis—Capecitabine—colon cancer	0.000181	0.000834	CcSEcCtD
Fluoxetine—Discomfort—Fluorouracil—colon cancer	0.000181	0.000832	CcSEcCtD
Fluoxetine—Shock—Irinotecan—colon cancer	0.00018	0.000829	CcSEcCtD
Fluoxetine—Thrombocytopenia—Irinotecan—colon cancer	0.000179	0.000825	CcSEcCtD
Fluoxetine—Anorexia—Vincristine—colon cancer	0.000179	0.000825	CcSEcCtD
Fluoxetine—Irritability—Methotrexate—colon cancer	0.000177	0.000816	CcSEcCtD
Fluoxetine—Hyperhidrosis—Irinotecan—colon cancer	0.000177	0.000815	CcSEcCtD
Fluoxetine—Confusional state—Fluorouracil—colon cancer	0.000177	0.000814	CcSEcCtD
Fluoxetine—Mood swings—Methotrexate—colon cancer	0.000176	0.000809	CcSEcCtD
Fluoxetine—Hypotension—Vincristine—colon cancer	0.000175	0.000809	CcSEcCtD
Fluoxetine—Bradycardia—Capecitabine—colon cancer	0.000175	0.000808	CcSEcCtD
Fluoxetine—Anaphylactic shock—Fluorouracil—colon cancer	0.000175	0.000807	CcSEcCtD
Fluoxetine—Anorexia—Irinotecan—colon cancer	0.000174	0.000803	CcSEcCtD
Fluoxetine—Ataxia—Methotrexate—colon cancer	0.000174	0.000803	CcSEcCtD
Fluoxetine—Infection—Fluorouracil—colon cancer	0.000174	0.000802	CcSEcCtD
Fluoxetine—Haemoglobin—Capecitabine—colon cancer	0.000173	0.000798	CcSEcCtD
Fluoxetine—Rhinitis—Capecitabine—colon cancer	0.000173	0.000796	CcSEcCtD
Fluoxetine—Haemorrhage—Capecitabine—colon cancer	0.000172	0.000794	CcSEcCtD
Fluoxetine—Hepatitis—Capecitabine—colon cancer	0.000172	0.000794	CcSEcCtD
Fluoxetine—Thrombocytopenia—Fluorouracil—colon cancer	0.000172	0.00079	CcSEcCtD
Fluoxetine—Hypoaesthesia—Capecitabine—colon cancer	0.000171	0.00079	CcSEcCtD
Fluoxetine—Liver function test abnormal—Methotrexate—colon cancer	0.000171	0.000789	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Vincristine—colon cancer	0.000171	0.000789	CcSEcCtD
Fluoxetine—Pharyngitis—Capecitabine—colon cancer	0.000171	0.000788	CcSEcCtD
Fluoxetine—Tachycardia—Fluorouracil—colon cancer	0.000171	0.000788	CcSEcCtD
Fluoxetine—Hypotension—Irinotecan—colon cancer	0.000171	0.000788	CcSEcCtD
Fluoxetine—Insomnia—Vincristine—colon cancer	0.00017	0.000783	CcSEcCtD
Fluoxetine—Oedema peripheral—Capecitabine—colon cancer	0.00017	0.000782	CcSEcCtD
Fluoxetine—Paraesthesia—Vincristine—colon cancer	0.000169	0.000777	CcSEcCtD
Fluoxetine—Breast disorder—Methotrexate—colon cancer	0.000168	0.000772	CcSEcCtD
Fluoxetine—Anorexia—Fluorouracil—colon cancer	0.000167	0.00077	CcSEcCtD
Fluoxetine—Toxic epidermal necrolysis—Methotrexate—colon cancer	0.000167	0.000769	CcSEcCtD
Fluoxetine—Visual impairment—Capecitabine—colon cancer	0.000166	0.000765	CcSEcCtD
Fluoxetine—Insomnia—Irinotecan—colon cancer	0.000165	0.000762	CcSEcCtD
Fluoxetine—Paraesthesia—Irinotecan—colon cancer	0.000164	0.000757	CcSEcCtD
Fluoxetine—Hypotension—Fluorouracil—colon cancer	0.000164	0.000754	CcSEcCtD
Fluoxetine—Decreased appetite—Vincristine—colon cancer	0.000163	0.000752	CcSEcCtD
Fluoxetine—Dyspnoea—Irinotecan—colon cancer	0.000163	0.000751	CcSEcCtD
Fluoxetine—Erythema multiforme—Capecitabine—colon cancer	0.000163	0.000751	CcSEcCtD
Fluoxetine—Somnolence—Irinotecan—colon cancer	0.000163	0.000749	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Vincristine—colon cancer	0.000162	0.000747	CcSEcCtD
Fluoxetine—Fatigue—Vincristine—colon cancer	0.000162	0.000746	CcSEcCtD
Fluoxetine—Dyspepsia—Irinotecan—colon cancer	0.000161	0.000742	CcSEcCtD
Fluoxetine—Tinnitus—Capecitabine—colon cancer	0.000161	0.00074	CcSEcCtD
Fluoxetine—Constipation—Vincristine—colon cancer	0.000161	0.00074	CcSEcCtD
Fluoxetine—Pain—Vincristine—colon cancer	0.000161	0.00074	CcSEcCtD
Fluoxetine—Asthma—Methotrexate—colon cancer	0.00016	0.000738	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Fluorouracil—colon cancer	0.00016	0.000735	CcSEcCtD
Fluoxetine—Decreased appetite—Irinotecan—colon cancer	0.000159	0.000733	CcSEcCtD
Fluoxetine—Eosinophilia—Methotrexate—colon cancer	0.000159	0.000731	CcSEcCtD
Fluoxetine—Insomnia—Fluorouracil—colon cancer	0.000158	0.00073	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Irinotecan—colon cancer	0.000158	0.000728	CcSEcCtD
Fluoxetine—Fatigue—Irinotecan—colon cancer	0.000158	0.000727	CcSEcCtD
Fluoxetine—Paraesthesia—Fluorouracil—colon cancer	0.000157	0.000725	CcSEcCtD
Fluoxetine—Pancreatitis—Methotrexate—colon cancer	0.000157	0.000724	CcSEcCtD
Fluoxetine—Pain—Irinotecan—colon cancer	0.000156	0.000721	CcSEcCtD
Fluoxetine—Constipation—Irinotecan—colon cancer	0.000156	0.000721	CcSEcCtD
Fluoxetine—Dyspnoea—Fluorouracil—colon cancer	0.000156	0.00072	CcSEcCtD
Fluoxetine—Somnolence—Fluorouracil—colon cancer	0.000156	0.000718	CcSEcCtD
Fluoxetine—Chills—Capecitabine—colon cancer	0.000155	0.000712	CcSEcCtD
Fluoxetine—Dyspepsia—Fluorouracil—colon cancer	0.000154	0.000711	CcSEcCtD
Fluoxetine—Arrhythmia—Capecitabine—colon cancer	0.000154	0.000709	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Vincristine—colon cancer	0.000154	0.000708	CcSEcCtD
Fluoxetine—ABCB1—lymph node—colon cancer	0.000153	0.00315	CbGeAlD
Fluoxetine—Decreased appetite—Fluorouracil—colon cancer	0.000152	0.000702	CcSEcCtD
Fluoxetine—Alopecia—Capecitabine—colon cancer	0.000152	0.000702	CcSEcCtD
Fluoxetine—Pancytopenia—Methotrexate—colon cancer	0.000152	0.000701	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Fluorouracil—colon cancer	0.000151	0.000697	CcSEcCtD
Fluoxetine—Mental disorder—Capecitabine—colon cancer	0.000151	0.000696	CcSEcCtD
Fluoxetine—Feeling abnormal—Irinotecan—colon cancer	0.000151	0.000695	CcSEcCtD
Fluoxetine—Malnutrition—Capecitabine—colon cancer	0.00015	0.000691	CcSEcCtD
Fluoxetine—Dysuria—Methotrexate—colon cancer	0.00015	0.000691	CcSEcCtD
Fluoxetine—Pain—Fluorouracil—colon cancer	0.00015	0.00069	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Irinotecan—colon cancer	0.00015	0.000689	CcSEcCtD
Fluoxetine—Upper respiratory tract infection—Methotrexate—colon cancer	0.000149	0.000686	CcSEcCtD
Fluoxetine—Abdominal pain—Vincristine—colon cancer	0.000148	0.000684	CcSEcCtD
Fluoxetine—Body temperature increased—Vincristine—colon cancer	0.000148	0.000684	CcSEcCtD
Fluoxetine—Flatulence—Capecitabine—colon cancer	0.000148	0.000681	CcSEcCtD
Fluoxetine—Erectile dysfunction—Methotrexate—colon cancer	0.000148	0.00068	CcSEcCtD
Fluoxetine—Dysgeusia—Capecitabine—colon cancer	0.000147	0.000677	CcSEcCtD
Fluoxetine—Photosensitivity reaction—Methotrexate—colon cancer	0.000146	0.000674	CcSEcCtD
Fluoxetine—Back pain—Capecitabine—colon cancer	0.000145	0.000669	CcSEcCtD
Fluoxetine—Body temperature increased—Irinotecan—colon cancer	0.000145	0.000666	CcSEcCtD
Fluoxetine—Abdominal pain—Irinotecan—colon cancer	0.000145	0.000666	CcSEcCtD
Fluoxetine—Feeling abnormal—Fluorouracil—colon cancer	0.000144	0.000665	CcSEcCtD
Fluoxetine—Muscle spasms—Capecitabine—colon cancer	0.000144	0.000665	CcSEcCtD
Fluoxetine—Pneumonia—Methotrexate—colon cancer	0.000144	0.000662	CcSEcCtD
Fluoxetine—Drowsiness—Methotrexate—colon cancer	0.000143	0.000658	CcSEcCtD
Fluoxetine—Depression—Methotrexate—colon cancer	0.000142	0.000657	CcSEcCtD
Fluoxetine—Stevens-Johnson syndrome—Methotrexate—colon cancer	0.000142	0.000653	CcSEcCtD
Fluoxetine—Tremor—Capecitabine—colon cancer	0.000141	0.000648	CcSEcCtD
Fluoxetine—Renal failure—Methotrexate—colon cancer	0.00014	0.000647	CcSEcCtD
Fluoxetine—Stomatitis—Methotrexate—colon cancer	0.000139	0.000642	CcSEcCtD
Fluoxetine—Ill-defined disorder—Capecitabine—colon cancer	0.000139	0.000641	CcSEcCtD
Fluoxetine—Urticaria—Fluorouracil—colon cancer	0.000139	0.000641	CcSEcCtD
Fluoxetine—Conjunctivitis—Methotrexate—colon cancer	0.000139	0.00064	CcSEcCtD
Fluoxetine—Anaemia—Capecitabine—colon cancer	0.000139	0.000639	CcSEcCtD
Fluoxetine—Body temperature increased—Fluorouracil—colon cancer	0.000138	0.000638	CcSEcCtD
Fluoxetine—Hypersensitivity—Vincristine—colon cancer	0.000138	0.000638	CcSEcCtD
Fluoxetine—Sweating—Methotrexate—colon cancer	0.000137	0.000631	CcSEcCtD
Fluoxetine—Haematuria—Methotrexate—colon cancer	0.000136	0.000628	CcSEcCtD
Fluoxetine—Malaise—Capecitabine—colon cancer	0.000135	0.000623	CcSEcCtD
Fluoxetine—Epistaxis—Methotrexate—colon cancer	0.000135	0.000621	CcSEcCtD
Fluoxetine—Vertigo—Capecitabine—colon cancer	0.000135	0.000621	CcSEcCtD
Fluoxetine—Hypersensitivity—Irinotecan—colon cancer	0.000135	0.000621	CcSEcCtD
Fluoxetine—Asthenia—Vincristine—colon cancer	0.000135	0.000621	CcSEcCtD
Fluoxetine—Syncope—Capecitabine—colon cancer	0.000135	0.00062	CcSEcCtD
Fluoxetine—Leukopenia—Capecitabine—colon cancer	0.000134	0.000619	CcSEcCtD
Fluoxetine—Palpitations—Capecitabine—colon cancer	0.000133	0.000611	CcSEcCtD
Fluoxetine—Loss of consciousness—Capecitabine—colon cancer	0.000132	0.000608	CcSEcCtD
Fluoxetine—Asthenia—Irinotecan—colon cancer	0.000131	0.000605	CcSEcCtD
Fluoxetine—Cough—Capecitabine—colon cancer	0.000131	0.000603	CcSEcCtD
Fluoxetine—Hypertension—Capecitabine—colon cancer	0.000129	0.000597	CcSEcCtD
Fluoxetine—Hypersensitivity—Fluorouracil—colon cancer	0.000129	0.000595	CcSEcCtD
Fluoxetine—Haemoglobin—Methotrexate—colon cancer	0.000129	0.000594	CcSEcCtD
Fluoxetine—Diarrhoea—Vincristine—colon cancer	0.000128	0.000592	CcSEcCtD
Fluoxetine—Haemorrhage—Methotrexate—colon cancer	0.000128	0.000591	CcSEcCtD
Fluoxetine—Hepatitis—Methotrexate—colon cancer	0.000128	0.000591	CcSEcCtD
Fluoxetine—Myalgia—Capecitabine—colon cancer	0.000128	0.000588	CcSEcCtD
Fluoxetine—Chest pain—Capecitabine—colon cancer	0.000128	0.000588	CcSEcCtD
Fluoxetine—Arthralgia—Capecitabine—colon cancer	0.000128	0.000588	CcSEcCtD
Fluoxetine—Pharyngitis—Methotrexate—colon cancer	0.000127	0.000587	CcSEcCtD
Fluoxetine—Anxiety—Capecitabine—colon cancer	0.000127	0.000586	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—colon cancer	0.000127	0.000584	CcSEcCtD
Fluoxetine—Discomfort—Capecitabine—colon cancer	0.000126	0.000581	CcSEcCtD
Fluoxetine—Diarrhoea—Irinotecan—colon cancer	0.000125	0.000577	CcSEcCtD
Fluoxetine—Dry mouth—Capecitabine—colon cancer	0.000125	0.000576	CcSEcCtD
Fluoxetine—Dizziness—Vincristine—colon cancer	0.000124	0.000572	CcSEcCtD
Fluoxetine—Pruritus—Fluorouracil—colon cancer	0.000124	0.000571	CcSEcCtD
Fluoxetine—Visual impairment—Methotrexate—colon cancer	0.000124	0.00057	CcSEcCtD
Fluoxetine—Confusional state—Capecitabine—colon cancer	0.000123	0.000569	CcSEcCtD
Fluoxetine—Infection—Capecitabine—colon cancer	0.000122	0.00056	CcSEcCtD
Fluoxetine—Erythema multiforme—Methotrexate—colon cancer	0.000121	0.000559	CcSEcCtD
Fluoxetine—Dizziness—Irinotecan—colon cancer	0.000121	0.000557	CcSEcCtD
Fluoxetine—Shock—Capecitabine—colon cancer	0.00012	0.000555	CcSEcCtD
Fluoxetine—Diarrhoea—Fluorouracil—colon cancer	0.00012	0.000552	CcSEcCtD
Fluoxetine—Thrombocytopenia—Capecitabine—colon cancer	0.00012	0.000552	CcSEcCtD
Fluoxetine—Tinnitus—Methotrexate—colon cancer	0.00012	0.000551	CcSEcCtD
Fluoxetine—Tachycardia—Capecitabine—colon cancer	0.000119	0.000551	CcSEcCtD
Fluoxetine—Vomiting—Vincristine—colon cancer	0.000119	0.00055	CcSEcCtD
Fluoxetine—Skin disorder—Capecitabine—colon cancer	0.000119	0.000548	CcSEcCtD
Fluoxetine—Rash—Vincristine—colon cancer	0.000118	0.000546	CcSEcCtD
Fluoxetine—Hyperhidrosis—Capecitabine—colon cancer	0.000118	0.000545	CcSEcCtD
Fluoxetine—Dermatitis—Vincristine—colon cancer	0.000118	0.000545	CcSEcCtD
Fluoxetine—Headache—Vincristine—colon cancer	0.000118	0.000542	CcSEcCtD
Fluoxetine—Anorexia—Capecitabine—colon cancer	0.000117	0.000538	CcSEcCtD
Fluoxetine—Vomiting—Irinotecan—colon cancer	0.000116	0.000536	CcSEcCtD
Fluoxetine—Dizziness—Fluorouracil—colon cancer	0.000116	0.000534	CcSEcCtD
Fluoxetine—Rash—Irinotecan—colon cancer	0.000115	0.000531	CcSEcCtD
Fluoxetine—Dermatitis—Irinotecan—colon cancer	0.000115	0.000531	CcSEcCtD
Fluoxetine—Chills—Methotrexate—colon cancer	0.000115	0.00053	CcSEcCtD
Fluoxetine—Headache—Irinotecan—colon cancer	0.000115	0.000528	CcSEcCtD
Fluoxetine—Hypotension—Capecitabine—colon cancer	0.000114	0.000527	CcSEcCtD
Fluoxetine—Alopecia—Methotrexate—colon cancer	0.000113	0.000522	CcSEcCtD
Fluoxetine—Mental disorder—Methotrexate—colon cancer	0.000112	0.000518	CcSEcCtD
Fluoxetine—Malnutrition—Methotrexate—colon cancer	0.000112	0.000515	CcSEcCtD
Fluoxetine—Nausea—Vincristine—colon cancer	0.000112	0.000514	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Capecitabine—colon cancer	0.000112	0.000514	CcSEcCtD
Fluoxetine—Vomiting—Fluorouracil—colon cancer	0.000111	0.000513	CcSEcCtD
Fluoxetine—Insomnia—Capecitabine—colon cancer	0.000111	0.00051	CcSEcCtD
Fluoxetine—Rash—Fluorouracil—colon cancer	0.00011	0.000509	CcSEcCtD
Fluoxetine—Dermatitis—Fluorouracil—colon cancer	0.00011	0.000509	CcSEcCtD
Fluoxetine—Paraesthesia—Capecitabine—colon cancer	0.00011	0.000507	CcSEcCtD
Fluoxetine—Headache—Fluorouracil—colon cancer	0.00011	0.000506	CcSEcCtD
Fluoxetine—Dysgeusia—Methotrexate—colon cancer	0.000109	0.000504	CcSEcCtD
Fluoxetine—Dyspnoea—Capecitabine—colon cancer	0.000109	0.000503	CcSEcCtD
Fluoxetine—Nausea—Irinotecan—colon cancer	0.000109	0.000501	CcSEcCtD
Fluoxetine—Back pain—Methotrexate—colon cancer	0.000108	0.000498	CcSEcCtD
Fluoxetine—Dyspepsia—Capecitabine—colon cancer	0.000108	0.000497	CcSEcCtD
Fluoxetine—Decreased appetite—Capecitabine—colon cancer	0.000106	0.00049	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Capecitabine—colon cancer	0.000106	0.000487	CcSEcCtD
Fluoxetine—Fatigue—Capecitabine—colon cancer	0.000106	0.000486	CcSEcCtD
Fluoxetine—Pain—Capecitabine—colon cancer	0.000105	0.000482	CcSEcCtD
Fluoxetine—Constipation—Capecitabine—colon cancer	0.000105	0.000482	CcSEcCtD
Fluoxetine—Nausea—Fluorouracil—colon cancer	0.000104	0.00048	CcSEcCtD
Fluoxetine—Ill-defined disorder—Methotrexate—colon cancer	0.000104	0.000477	CcSEcCtD
Fluoxetine—Anaemia—Methotrexate—colon cancer	0.000103	0.000476	CcSEcCtD
Fluoxetine—Feeling abnormal—Capecitabine—colon cancer	0.000101	0.000465	CcSEcCtD
Fluoxetine—Malaise—Methotrexate—colon cancer	0.000101	0.000464	CcSEcCtD
Fluoxetine—Vertigo—Methotrexate—colon cancer	0.0001	0.000462	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Capecitabine—colon cancer	0.0001	0.000461	CcSEcCtD
Fluoxetine—Leukopenia—Methotrexate—colon cancer	9.99e-05	0.000461	CcSEcCtD
Fluoxetine—Cough—Methotrexate—colon cancer	9.74e-05	0.000449	CcSEcCtD
Fluoxetine—Urticaria—Capecitabine—colon cancer	9.72e-05	0.000448	CcSEcCtD
Fluoxetine—Abdominal pain—Capecitabine—colon cancer	9.68e-05	0.000446	CcSEcCtD
Fluoxetine—Body temperature increased—Capecitabine—colon cancer	9.68e-05	0.000446	CcSEcCtD
Fluoxetine—Convulsion—Methotrexate—colon cancer	9.67e-05	0.000446	CcSEcCtD
Fluoxetine—Chest pain—Methotrexate—colon cancer	9.51e-05	0.000438	CcSEcCtD
Fluoxetine—Myalgia—Methotrexate—colon cancer	9.51e-05	0.000438	CcSEcCtD
Fluoxetine—Arthralgia—Methotrexate—colon cancer	9.51e-05	0.000438	CcSEcCtD
Fluoxetine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—colon cancer	9.44e-05	0.000435	CcSEcCtD
Fluoxetine—Discomfort—Methotrexate—colon cancer	9.39e-05	0.000433	CcSEcCtD
Fluoxetine—Confusional state—Methotrexate—colon cancer	9.19e-05	0.000423	CcSEcCtD
Fluoxetine—Anaphylactic shock—Methotrexate—colon cancer	9.11e-05	0.00042	CcSEcCtD
Fluoxetine—Infection—Methotrexate—colon cancer	9.05e-05	0.000417	CcSEcCtD
Fluoxetine—Hypersensitivity—Capecitabine—colon cancer	9.02e-05	0.000416	CcSEcCtD
Fluoxetine—Thrombocytopenia—Methotrexate—colon cancer	8.92e-05	0.000411	CcSEcCtD
Fluoxetine—Skin disorder—Methotrexate—colon cancer	8.85e-05	0.000408	CcSEcCtD
Fluoxetine—Hyperhidrosis—Methotrexate—colon cancer	8.81e-05	0.000406	CcSEcCtD
Fluoxetine—Asthenia—Capecitabine—colon cancer	8.78e-05	0.000405	CcSEcCtD
Fluoxetine—Anorexia—Methotrexate—colon cancer	8.69e-05	0.0004	CcSEcCtD
Fluoxetine—Pruritus—Capecitabine—colon cancer	8.66e-05	0.000399	CcSEcCtD
Fluoxetine—Hypotension—Methotrexate—colon cancer	8.52e-05	0.000392	CcSEcCtD
Fluoxetine—Diarrhoea—Capecitabine—colon cancer	8.38e-05	0.000386	CcSEcCtD
Fluoxetine—Musculoskeletal discomfort—Methotrexate—colon cancer	8.3e-05	0.000383	CcSEcCtD
Fluoxetine—Insomnia—Methotrexate—colon cancer	8.24e-05	0.00038	CcSEcCtD
Fluoxetine—Paraesthesia—Methotrexate—colon cancer	8.18e-05	0.000377	CcSEcCtD
Fluoxetine—Dyspnoea—Methotrexate—colon cancer	8.12e-05	0.000374	CcSEcCtD
Fluoxetine—Somnolence—Methotrexate—colon cancer	8.1e-05	0.000373	CcSEcCtD
Fluoxetine—Dizziness—Capecitabine—colon cancer	8.09e-05	0.000373	CcSEcCtD
Fluoxetine—Dyspepsia—Methotrexate—colon cancer	8.02e-05	0.00037	CcSEcCtD
Fluoxetine—Decreased appetite—Methotrexate—colon cancer	7.92e-05	0.000365	CcSEcCtD
Fluoxetine—Gastrointestinal disorder—Methotrexate—colon cancer	7.87e-05	0.000363	CcSEcCtD
Fluoxetine—Fatigue—Methotrexate—colon cancer	7.86e-05	0.000362	CcSEcCtD
Fluoxetine—Pain—Methotrexate—colon cancer	7.79e-05	0.000359	CcSEcCtD
Fluoxetine—Vomiting—Capecitabine—colon cancer	7.78e-05	0.000359	CcSEcCtD
Fluoxetine—Rash—Capecitabine—colon cancer	7.72e-05	0.000356	CcSEcCtD
Fluoxetine—Dermatitis—Capecitabine—colon cancer	7.71e-05	0.000355	CcSEcCtD
Fluoxetine—Headache—Capecitabine—colon cancer	7.67e-05	0.000353	CcSEcCtD
Fluoxetine—Feeling abnormal—Methotrexate—colon cancer	7.51e-05	0.000346	CcSEcCtD
Fluoxetine—Gastrointestinal pain—Methotrexate—colon cancer	7.45e-05	0.000343	CcSEcCtD
Fluoxetine—Nausea—Capecitabine—colon cancer	7.27e-05	0.000335	CcSEcCtD
Fluoxetine—Urticaria—Methotrexate—colon cancer	7.24e-05	0.000334	CcSEcCtD
Fluoxetine—Abdominal pain—Methotrexate—colon cancer	7.2e-05	0.000332	CcSEcCtD
Fluoxetine—Body temperature increased—Methotrexate—colon cancer	7.2e-05	0.000332	CcSEcCtD
Fluoxetine—Hypersensitivity—Methotrexate—colon cancer	6.71e-05	0.000309	CcSEcCtD
Fluoxetine—Asthenia—Methotrexate—colon cancer	6.54e-05	0.000301	CcSEcCtD
Fluoxetine—Pruritus—Methotrexate—colon cancer	6.45e-05	0.000297	CcSEcCtD
Fluoxetine—Diarrhoea—Methotrexate—colon cancer	6.24e-05	0.000287	CcSEcCtD
Fluoxetine—Dizziness—Methotrexate—colon cancer	6.03e-05	0.000278	CcSEcCtD
Fluoxetine—Vomiting—Methotrexate—colon cancer	5.79e-05	0.000267	CcSEcCtD
Fluoxetine—Rash—Methotrexate—colon cancer	5.75e-05	0.000265	CcSEcCtD
Fluoxetine—Dermatitis—Methotrexate—colon cancer	5.74e-05	0.000265	CcSEcCtD
Fluoxetine—Headache—Methotrexate—colon cancer	5.71e-05	0.000263	CcSEcCtD
Fluoxetine—Nausea—Methotrexate—colon cancer	5.41e-05	0.000249	CcSEcCtD
